search img
Ready-To-Use primary packaging for flexible aseptic operations 2021 - Stevanato Group
Stevanato Group is glad to be one of the speakers of SGD Pharma's webinar on:Ready-To-Use primary packaging for flexible aseptic operations
Home - Integrated solutions for pharma & healthcare - Stevanato Group > News & Events - Stevanato Group > Webinars - Stevanato Group > Ready-To-Use primary packaging for flexible aseptic operations 2021 - Stevanato Group

Ready-To-Use primary packaging for flexible aseptic operations

27 May 2021

Stevanato Group is glad to be one of the speakers of SGD Pharma's webinar on:

Ready-To-Use primary packaging for flexible aseptic operations - How to gain speed to the market with a multi-sourcing approach

Webinar Details:

  • Date: Thursday, May 27th 
  • Time: 4.00 pm CET / 10.00 am EST / 3.00 pm (GMT -1)
  • Duration: 60 minutes, including Q&A
  • Language: English



Reserve your seat now to enjoy the webinar!

Webinar abstract:

The pharmaceutical industry is experiencing a shift from blockbuster to biological drugs for more personalized treatments. This trend results in a need for pharmaceutical companies to manufacture smaller batches and handle multiple products in different container presentations on the same filling line, driving the adoption of Ready-To-Use (RTU) primary packaging. Although the technology of combi-lines and RTU is well established in the market, there are still few options for primary packaging available.

To ensure manufacturing readiness, a key aspect that pharma companies take into account when selecting the technology is the possibility of multiple sourcing along their supply chain. Flexibility, quality, and low Total Cost of Ownership (TCO) are key criteria when selecting packaging partners for fill & finish operations.

This presentation demonstrates how the partnership between Stevanato Group and SGD Pharma on RTU molded glass vials has supported a real case of switching manufacturing process from bulk to EZ-fill®, illustrated by the pharma company TERIAK. The adoption of the same secondary packaging for different glass primary packaging containers, i.e., vials, has enabled a multi-sourcing approach without impacting line format change at TERIAK’s pharma operations.

Key Learning Objectives:

  • Understand how SG EZ-Fill pre-sterilized platform can help your pharma company gain flexibility
  • Learn more about a real case study on the multi-sourcing approach
  • Get insights from leading market players about aseptic manufacturing using Ready To Fill containers
  • Get to know Sterinity: benefits of pre-sterilized molded glass

Who Should Attend:

Recommended attendees include those who are:

  • Head/Vice President of Innovation
  • Head of primary packaging development
  • Manager of R&D primary packaging
  • Packaging development manager
  • Vice president of operations
  • Scientific in charge of new drugs developments
  • Head/Director/Vice president of operations
  • Head/Director/Vice president of Manufacturing operations
  • Process/Product Development Manager
  • Head/Director/Vice president of procurement
  • Sourcing Manager
  • Purchasing Manager
  • Plant Manager
  • Project Manager
  • Project manager of new production facilities
  • Aseptic area manager
  • Research & Development Engineer
  • Quality Assurance engineer

About the speakers:

Riccardo Prete

Product Manager for the Vial Platform, Stevanato Group

Riccardo Prete is currently part of Product Management team of Stevanato Group, overseeing the sterile and bulk glass vials business. With a background in Economics and a Master’s Degree in Business Administration from Ca’ Foscari University of Venice, he joined Stevanato Group in 2017 as Product Specialist for Glass bulk products.

Alexander Bautista

Product Manager for Sterinity: molded glass vials RTU platform, SGD Pharma

Alexander Bautista is currently corporate Product Manager of Sterinity RTU molded vials platform at SGD Pharma, based in France. He joined SGD Pharma in 2015 as Sales Manager, and he has strong experience in molded glass packaging for pharmaceutical use in different markets around the world. Before SGD Pharma, he worked for six years at Procter & Gamble as a Project Manager Engineer. Alexander Bautista has a master’s degree in Industrial Engineering and an executive degree in International Business Management.

Noureddine Ghariani

Head of biologic project / Site Manager of ELFEJJA Site, Teriak

Noureddine Ghariani is currently the Head of Biotechnology project at Teriak at Elfejja site based in Tunisia, he has an experience of 24 years in pharmaceutical industry and has held many positions in various departments such as Production Director, Quality Assurance Director, Qualified Person and Technical Director and Head of R&D department and Regulatory Affairs. He has a doctorate in Pharmacy and has an executive MBA from MSB.